HIGHLIGHTS
- who: Elena Bozzola from the The Chinese University of Hong Kong, Hong Kong SAR, China have published the Article: The assessment of future RSV immunizations: How to protect all infants?, in the Journal: (JOURNAL)
SUMMARY
Although preterm infants or infants with co-morbidity have a higher risk of having a severe infection, ~80% of infants hospitalized with RSV are otherwise healthy, i.e., with no underlying medical conditions, and born at term. In an annual cohort of infants, RSV disease burden and associated costs (including hospitalization and outpatient visit costs) are created mostly . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.